Seraphim Space Investment Trust (LSE: SSIT) leans on ICEYE re-rating and SpaceX IPO tailwind to consolidate FTSE 250 entry
Read More Healthcare Industry News Can Beyond Air’s $32m lifeline drive profitability and global adoption of LungFit PH? Find out how Beyond Air’s $32 million lifeline could drive profitability and global adoption of its LungFit PH nitric oxide therapy device. bySoujanya RaviNovember 5, 2025